# US 8,277,782 B2 · Topical oral care compositions comprising host response modulating agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,782 B2
- Document ID: US8277782B2
- Status: Granted
- Kind: B2
- Application number: 11/409,850
- Filed: 2006-04-24
- Published: 2006-08-31
- Granted: 2012-10-02
- Earliest claimed: 2000-06-30
- Assignees: The Procter & Gamble Company
- Inventors: Matthew Joseph Doyle; Stephen Joseph Hunter-Rinderle; Robert Ernest Singer, Jr.
- Web page: https://patentgrep.com/patent/US8277782B2

## CPC

- A61K 8/4946: {Imidazoles or their condensed derivatives, e.g. benzimidazoles}
- A61K 8/4973: {with oxygen as the only hetero atom}
- A61K 31/00: Medicinal preparations containing organic active ingredients
- A61K 31/407: condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A61K 31/4164: 1,3-Diazoles
- A61K 31/426: 1,3-Thiazoles
- A61K 31/662: Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61Q 11/00: Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention relates to topical oral care compositions comprising in a pharmaceutically acceptable carrier a safe and effective amount of a host-response modulating agent including one or more of an anti-oxidant and modifier of cell redox status, anti-inflammatory agent, metalloproteinase inhibitor, vitamins and nutrients key to maintenance of a host response balance and inhibitor of activation of NF-kB in combination with one or a mixture of additional oral therapeutic actives selected from antimicrobial/antiplaque agents, biofilm inhibiting agents, antibiotics; analgesics and local anesthetic agents; dentinal desensitizing agents and odor masking agents. The present compositions are effective in treating and preventing bacteria-mediated diseases present in the oral cavity and in mediating host reaction to the presence of pathogenic bacteria in the oral cavity as well as the toxins and endotoxins, inflammatory cytokines and mediators released or prompted by these oral pathogens. By controlling bacteria-mediated diseases and conditions present in the oral cavity and modulating host reaction, spread into the bloodstream and other parts of the body of pathogenic bacteria and associated harmful substances is prevented or minimized.

## Claims

### Claim 1

A topical oral care composition for controlling oral cavity bacterial infection and reducing risk of developing an oral bacteria-induced systemic disease in human and other animal subjects, said composition consisting essentially of:
a) a safe and effective amount of a combination of anti-oxidant and H2-antagonist host-response modulating agents, wherein the anti-oxidant is selected from one or a mixture of gallic acid, N-acetyl cysteine, or anethole dithiolthione and the H2-antagonist is selected from one or a mixture of cimetidine, etintidine, ranitidine, tiotidine, lupitidine, donetidine, famotidine, roxatidine, pifatidine, lamtidine, zaltidine, nizatidine, mifentidine, ramixotidine, loxtidine, bisfentidine, sufotidine, ebrotidine, or impromidine,
b) a safe and effective amount of an additional oral therapeutic active selected from one or a mixture of antimicrobial/antiplaque agents selected from benzalkonium chloride, salicylanilide, domiphen bromide, cetylpyridinium chloride, tetradecylpyridinium chloride, and N-tetradecyl-4-ethylpyridinium chloride, and
c) a pharmaceutically acceptable oral carrier.

### Claim 2 (depends on 1)

A topical oral care composition according to claim 1 in a form selected from a mouthrinse, toothpaste, tooth gel, tooth powder, non-abrasive gel, chewing gum, mouth spray, lozenge, dental implement, and a pet care product.
